hydralazine has been researched along with peroxynitrous acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bachschmid, M; Coldewey, M; Daiber, A; Huth, C; Kaiser, K; Mülsch, A; Münzel, T; Nazirisadeh, Y; Oelze, M; Schildknecht, S; Tsilimingas, N; Ullrich, V | 1 |
1 other study(ies) available for hydralazine and peroxynitrous acid
Article | Year |
---|---|
Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure.
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; Animals; Antioxidants; Cell Adhesion Molecules; Drug Tolerance; Free Radical Scavengers; Heart Failure; Humans; Hydralazine; Male; Microfilament Proteins; Mitochondria; Mitochondrial Proteins; Nitroglycerin; Oxidative Stress; Peroxynitrous Acid; Phosphoproteins; Prognosis; Rats; Rats, Wistar; Reactive Nitrogen Species; Reactive Oxygen Species | 2005 |